Anti-PD-1 Antibody Therapies of Camrelizumab in Combination With Pemetrexed and Carboplatin as First-line Treatment in Patients With Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
חו"ל (דורש נסיעה)מגייס משתתפיםPHASE2
מצבים רפואיים
Non Squamous Non Small Cell Lung Cancer
סיכום בשפה פשוטהבעזרת בינה מלאכותית
הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.
מיקומים
Korea University Anam Hospital, Anam, South Korea
Contact: Study coordinator (Sooin Choi, M.D.)Hallym University Sacred Heart Hospital, Anyang, South Korea
Contact: Study coordinator (Seung Hoon Jang)Chonnam National University Hwasun Hospital, Hwasun, South Korea
Contact: Study coordinator (Injae Oh, M.D.)Catholic University of Korea EunPyeong St. Mary's Hospital, Seoul, South Korea
Contact: Study coordinator (Chang Dong Yeo, M.D.)Catholic University of Korea Yeouido St. Mary's Hospital, Seoul, South Korea
Contact: Study coordinator (Chan Kwon Park, M.D.)Korea University Guro Hospital, Seoul, South Korea
Contact: Study coordinator (Sung Yong Lee, M.D.)Seoul Asan Hospital, Seoul, South Korea
Contact: Study coordinator (Chang Min Choi, M.D.)Busan National University Hospital Yangsan, Yangsan, South Korea
Contact: Study coordinator (Sunghoon Yoon, M.D.)
מובילי המחקר
Sung Yong Lee, MD
Principal Investigator
Korea University Guro Hospital